Bristol-Myers Squibb - Global Biopharmaceutical Company
Exploring the research behind why some people respond to immunotherapy and others do not.
How we're responding
The global spread of COVID-19 is affecting each of us and the communities in which we live and work in different ways. Learn more about how Bristol Myers Squibb UK and Ireland is responding to the pandemic.
NOIE2010642-01 Date of Preparation: November 2020